ArthroCare

ArthroCare (NASDAQ: ARTC) is a United States-based public company in the field of medical devices.[1] The prime focus of the company is soft tissue repair and ablation technology in the medical areas of larger joints (knee, hip, and shoulder), spine as well as ENT.

Controversies[edit]

In 2008, several class actions were filed against ArthroCare, alleging that ArthroCare issued materially false and misleading statements and failed to disclose some adverse facts. In 2012, a settlement of $74 million was approved.[2]

References[edit]

  1. ^ Dealbook (18 August 2009). "One Equity Partners has signed an agreement with ArthroCare that will provide the latter with a $75 million infusion". The New York Times. Retrieved 2011-04-01.
  2. ^ "Class Action Lawsuit Against ArthroCare". Archived from the original on 2013-06-19.

External links[edit]